  There is an increasing interest to develop nanoscale biocompatible graphene
structures due to their desirable physicochemical properties, unlimited
application opportunities and scalable production. Here we report the
preparation, characterization and biocompatibility assessment of novel graphene
flakes and their enabled thin films suitable for a wide range of biomedical and
electronic applications. Graphene flakes were synthesized by a chemical vapour
deposition method or a liquid-phase exfoliation procedure and then thin films
were prepared by transferring graphene onto glass coverslips. Raman
spectroscopy and transmission electron microscopy confirmed a predominantly
monolayer and a high crystalline quality formation of graphene. The
biocompatibility assessment of graphene thin films and graphene flakes was
performed using cultured human lung epithelial cell line A549 employing a
multimodal approach incorporating automated imaging, high content screening,
real-time impedance sensing in combination with biochemical assays. No
detectable changes in the cellular morphology or attachment of A549 cells
growing on graphene thin films or cells exposed to graphene flakes (0.1 to 5
ug/mL) for 4 to 72 h was observed. Graphene treatments caused a very low level
of increase in cellular production of reactive oxygen species in A549 cells,
but no detectable damage to the nuclei such as changes in morphology,
condensation or fragmentation was observed. In contrast, carbon black proved to
be significantly more toxic than the graphene. These data open up a promising
view of using graphene enabled composites for a diverse scope of safer
applications.
